Clinical Trial Update: Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prophylactic intracoronary adenosine to prevent post-stenting myonecrosis in patients with coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Stenosis, Coronary Artery Disease | Phase 3 | Status: TERMINATED